This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | P030040S001 |
Classification Name | None |
Applicant | |
PMA | P030040 |
Supplement | S001 |
Supplement Number | Date | Supplement Type |
---|---|---|
P030040 | Original Filing | |
S021 | 2022-03-22 | 30-day Notice |
S020 | 2021-04-01 | 30-day Notice |
S019 | 2020-12-22 | Real-time Process |
S018 | 2020-07-31 | 30-day Notice |
S017 | 2020-03-09 | 30-day Notice |
S016 | 2020-02-21 | 30-day Notice |
S015 | 2019-02-01 | 30-day Notice |
S014 | 2018-08-15 | Normal 180 Day Track No User Fee |
S013 | 2018-07-19 | Real-time Process |
S012 | 2017-06-16 | Normal 180 Day Track |
S011 | 2016-07-05 | Normal 180 Day Track |
S010 | 2015-06-11 | 30-day Notice |
S009 | 2015-05-14 | Normal 180 Day Track |
S008 | 2012-03-26 | Normal 180 Day Track No User Fee |
S007 | 2010-02-18 | 30-day Notice |
S006 | 2009-05-18 | Normal 180 Day Track |
S005 | 2009-03-31 | Normal 180 Day Track |
S004 | 2009-03-09 | Normal 180 Day Track No User Fee |
S003 | 2009-02-04 | 30-day Notice |
S002 | 2008-08-11 | Normal 180 Day Track |
S001 |
Device ID | PMA | Supp |
---|---|---|
00630414978017 | P030040 | 000 |
00630414597805 | P030040 | 000 |
00630414470504 | P030040 | 000 |
00630414597799 | P030040 | 002 |
00630414470498 | P030040 | 002 |
00630414301266 | P030040 | 002 |